PTPN11 and neoplasm: The reduced vascularization of tumors derived from inoculation of SHP2-silenced cell lines, which are themselves growth–insensitive to SHP2 depletion, was unexpectedly uncoupled from reduced tumor growth at endpoint (Figure 1, B, C, I, and J, and Supplemental Figure 1, B and M).